OnKure Therapeutics, Inc. OKUR Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s change in AP?
- OnKure Therapeutics, Inc. (OKUR) reported change in AP of -$905K in Q1 2026.
- How has OnKure Therapeutics, Inc.'s change in AP changed year-over-year?
- OnKure Therapeutics, Inc.'s change in AP increased by 46.1% year-over-year, from -$1.68M to -$905K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s change in AP?
- Over 2 years (2021 to 2025), OnKure Therapeutics, Inc.'s change in AP has grown at a 58.2% compound annual growth rate (CAGR), from $1.82M to -$4.55M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.